Piperine Vitiligo Treatment Could Come from Pepper

Vitiligo Patients Impatient

There’s a new hottie in town, and it’s called piperine. Vitiligo sufferers are excited about the potential effects piperine could have on their white patches of skin. Vitiligo affects approximately one half to one percent of the population, with dark-skinned patients being the most obviously affected. Piperine is the part of black pepper that smells strongly.

Hello, Piperine – Good-Bye, Vitiligo?

According to carefare.com, “New research by British scientists may point to hope for those suffering from vitiligo. A study conducted at King’s College London showed that piperine, the pungent flavor in black pepper, helped stimulate skin pigmentation. Importantly, synthetic derivatives of piperine also showed themselves effective. The combination of piperine and currently existing ultraviolet phototherapy techniques proved even more effective.”

Piperine combined with radiation also proved effective. Antony Young (a King’s College photobiologist) said, “We have shown that topical treatment with piperine stimulates even pigmentation in the skin. This provides support for the future clinical evaluation of piperine and its derivatives as novel treatments for vitiligo.”

More Studies Needed on Piperine – Vitiligo Patients Impatient

Scientists say more testing is needed before piperine will be approved for marketing. Vitiligo sufferers feel that a span of up to ten years is far too long to wait. However, one company claims they have the answer; according to the Bioperine® website, “BioPerine® is the only product sourced out of piperine to obtain a patented status for its ability to increase the bioavailability of nutritional compounds. Secondly, it is the only source from piperine to have undergone clinical studies in the U.S. to substantiate its safety and efficacy for nutritional use.”

Bioperine® is marketed as a nutritional absorption aid, with an emphasis on betacarotene, B6 vitamins, and selenium. It is still not marketed as a prescription for vitiligo, and researchers pursuing a piperine drug trial now say that funding has been cut, according to Nathalie Pelletier ofVitiligo Corner:

“Yesterday I contacted Dr. Soumyana to get an update on the piperine research which she founded. Here is what she said:

‘We are presently seeking external funding to do a safety trial of piperine in vitiligo. The economic downturn has meant that we could not proceed as fast as we would have liked, but rest assured that we are still working on this project.'”

If piperine is safe, it is hoped that a marketable version will be available soon.